OTCM
ITXXF
Market cap32mUSD
Aug 13, Last price
2.29USD
Name
Itaconix PLC
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Itaconix plc, alongside its affiliated entities, specializes in the creation, production, and distribution of bio-based polymers. These innovative materials serve the personal care, household product, and industrial sectors throughout North America and Europe. For home and industrial applications, its offerings encompass water-soluble polymers like Itaconix TSI, Itaconix DSP, Itaconix CHT, and Itaconix VELASOFT, as well as water-soluble odor neutralizers such as Itaconix ZINADOR 22L and 35L. In the personal care market, Itaconix supplies water-soluble fixating complexes, specifically Itaconix VELAFRESH ZP20 and ZP30, along with Nouryon Amaze SP, an ingredient for hair styling. Established in 2012, the company operated as Revolymer plc before adopting its current name, Itaconix plc, in February 2017. The firm's main office is located in Stratham, New Hampshire.
Key people
John Shaw
Chief Executive Officer, Executive Director · since 2018
Laura Denner
Chief Financial Officer, Executive Director, Company Secretary · since 2022
Peter Nieuwenhuizen
Independent Non-Executive Chairman of the Board · since 2023
Jonathan Brooks
Non-Executive Independent Director · since 2024
Paul Leblanc
Non-Executive Independent Director · since 2023
IPO date
Jul 10, 2012
Employees
13
Domiciled in
GB
Incorporated in
GB
Legal address
FIELDFISHER RIVERBANK HOUSE
2 SWAN LANE
LONDON, LND EC4R 3TT
GB
2 SWAN LANE
LONDON, LND EC4R 3TT
GB
Headquarters
2 MARIN WAY
STRATHAM, NH 03885
US
STRATHAM, NH 03885
US
Previous name
REVOLYMER PLC
Previous name
REVOLYMER (U.K.) PLC
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||